Phosphorylated NFS1 weakens oxaliplatin-based chemosensitivity of colorectal cancer by preventing PANoptosis.
Lin JF, Hu PS, Wang YY, Tan YT, Yu K, Liao K, Wu QN, Li T, Meng Q, Lin JZ, Liu ZX, Pu HY, Ju HQ, Xu RH, Qiu MZ.
Lin JF, et al. Among authors: hu ps.
Signal Transduct Target Ther. 2022 Feb 28;7(1):54. doi: 10.1038/s41392-022-00889-0.
Signal Transduct Target Ther. 2022.
PMID: 35221331
Free PMC article.